(Q74200194)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10951498%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Low-dose staurosporine suppresses proliferation and induces neurites in human prostatic cancer TSU-Pr1 cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10951498%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

N Takahashi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10951498%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

T Shimizu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10951498%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

K Takeda

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10951498%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10951498%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10951498%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10951498%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10951498%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

328-333

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10951498%20AND%20SRC:MED&resulttype=core&format=json

The influence of hormonal therapy on survival of men with advanced prostatic cancer.

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000901%2944%3A4%3C328%3A%3AAID-PROS10%3E3.0.CO%3B2-8

Differentiation therapy of leukemia: achievements, limitations and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000901%2944%3A4%3C328%3A%3AAID-PROS10%3E3.0.CO%3B2-8

Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000901%2944%3A4%3C328%3A%3AAID-PROS10%3E3.0.CO%3B2-8

Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000901%2944%3A4%3C328%3A%3AAID-PROS10%3E3.0.CO%3B2-8

Interleukin-6 induces G1 arrest through induction of p27(Kip1), a cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000901%2944%3A4%3C328%3A%3AAID-PROS10%3E3.0.CO%3B2-8

Regulation of invasive potential of human prostate cancer cell lines by hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000901%2944%3A4%3C328%3A%3AAID-PROS10%3E3.0.CO%3B2-8

Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000901%2944%3A4%3C328%3A%3AAID-PROS10%3E3.0.CO%3B2-8

Selective activation of p42 mitogen-activated protein (MAP) kinase in murine B lymphoma cell lines by membrane immunoglobulin cross-linking. Evidence for protein kinase C-independent and -dependent mechanisms of activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000901%2944%3A4%3C328%3A%3AAID-PROS10%3E3.0.CO%3B2-8

Staurosporine: An Effective Inhibitor for Ca2+/Calmodulin-Dependent Protein Kinase II

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000901%2944%3A4%3C328%3A%3AAID-PROS10%3E3.0.CO%3B2-8

Staurosporine is a potent inhibitor of p34cdc2 and p34cdc2-like kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000901%2944%3A4%3C328%3A%3AAID-PROS10%3E3.0.CO%3B2-8

Establishment of a new prostatic carcinoma cell line (TSU-Pr1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000901%2944%3A4%3C328%3A%3AAID-PROS10%3E3.0.CO%3B2-8

The molecular and cellular biology of tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000901%2944%3A4%3C328%3A%3AAID-PROS10%3E3.0.CO%3B2-8

Neurite differentiation is modulated in neuroblastoma cells engineered for altered acetylcholinesterase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000901%2944%3A4%3C328%3A%3AAID-PROS10%3E3.0.CO%3B2-8

Differentiation of cultured neuroblastoma induced by staurosporine and cyclic AMP: methods for assessing a neuronal phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000901%2944%3A4%3C328%3A%3AAID-PROS10%3E3.0.CO%3B2-8

Induction of apoptosis in prostatic tumor cell line DU145 by staurosporine, a potent inhibitor of protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000901%2944%3A4%3C328%3A%3AAID-PROS10%3E3.0.CO%3B2-8

Inhibition of chemomigration of a human prostatic carcinoma cell (TSU-pr1) line by inhibition of epidermal growth factor receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000901%2944%3A4%3C328%3A%3AAID-PROS10%3E3.0.CO%3B2-8

The accumulation of cyclin-dependent kinase inhibitor p27kip1 is a primary response to staurosporine and independent of G1 cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000901%2944%3A4%3C328%3A%3AAID-PROS10%3E3.0.CO%3B2-8

Inhibition of tumor formation from grafted murine papilloma cells by treatment of grafts with staurosporine, an inducer of squamous differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000901%2944%3A4%3C328%3A%3AAID-PROS10%3E3.0.CO%3B2-8

Analogs of staurosporine: potential anticancer drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000901%2944%3A4%3C328%3A%3AAID-PROS10%3E3.0.CO%3B2-8

10.1002/1097-0045(20000901)44:4<328::AID-PROS10>3.0.CO;2-8

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10951498%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference